Skip to main content
Premium Trial:

Request an Annual Quote

Genalice, Decode Partner on Population-wide Genome Analysis

NEW YORK (GenomeWeb) – Dutch bioinformatics company Genalice today announced a partnership with Decode Genetics for large-scale testing of the DNA data processing software Genalice Map.

The companies successfully completed a first round that evaluated Genalice Map's speed and quality, and in the new partnership, they will evaluate up to an additional 10,000 full human genomes. Genalice is providing its bioinformatics product Genalice Vault, which is preloaded with Map for the processing of one human genome per minute.

The project will begin in August and final results are anticipated to be available in December.

Genalice said that population-wide analysis is crucial for whole-genome sequencing to have applications in the clinic, especially for complex diseases. A major challenge has been data processing, and Genalice seeks to address this with technology that can process a full human genome on general purpose hardware in minutes.

"We are pleased to move into a second phase with the aim [of stress testing] the software at [the] population calling level and collaboration on further refinements," Decode VP of Informatics Hakon Gudbjartsson said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.